Lasix, or furosemide, powerfully increases urine production by directly inhibiting sodium and chloride reabsorption in the thick ascending limb of the loop of Henle in the kidneys.
- This inhibition dramatically reduces the kidney’s ability to reabsorb sodium and chloride ions. Consequently, more sodium and chloride remain in the tubular fluid. Water follows these ions osmotically, leading to increased urine volume.
This process affects several key areas:
Sodium Reabsorption: Lasix significantly blocks the sodium-potassium-chloride cotransporter (NKCC2), a vital protein for sodium reabsorption in the loop of Henle. Reduced sodium reabsorption is the primary mechanism driving increased urine output. Potassium Excretion: While Lasix’s primary action is on sodium, it also affects potassium excretion. Increased distal tubular flow secondary to increased sodium delivery can enhance potassium loss. This is why potassium-sparing diuretics are often co-prescribed. Calcium Excretion: Lasix can modestly increase calcium excretion, though the effects are less pronounced than its impact on sodium and potassium. Magnesium Excretion: Similar to calcium, magnesium excretion can also be slightly increased.
Understanding these mechanisms helps explain Lasix’s therapeutic effects, including its use in treating edema associated with heart failure, liver cirrhosis, and kidney disease, as well as its role in managing hypertension.
